Oncolytics Biotech’s (ONCY) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright restated their buy rating on shares of Oncolytics Biotech (NASDAQ:ONCY – Free Report) in a research report report published on Monday,Benzinga reports. They currently have a $5.00 target price on the stock. A number of other analysts have also recently weighed in on ONCY. Leede Financial cut shares of Oncolytics Biotech from a […]
HC Wainwright restated their buy rating on shares of Oncolytics Biotech (NASDAQ:ONCY – Free Report) in a research report report published on Monday,Benzinga reports. They currently have a $5.00 target price on the stock. A number of other analysts have also recently weighed in on ONCY. Leede Financial cut shares of Oncolytics Biotech from a […]
